AAAAAA

   
Results: 1-9 |
Results: 9
H2-M beta 1 and H2-M beta 2 heterodimers equally promote CLIP removal in I-A(q) molecules from autoimmune-prone DBA/1 mice
Authors: Walter, W Scheuer, C Loos, M Reichert, TE Maeurer, MJ
Citation: W. Walter et al., H2-M beta 1 and H2-M beta 2 heterodimers equally promote CLIP removal in I-A(q) molecules from autoimmune-prone DBA/1 mice, J BIOL CHEM, 276(14), 2001, pp. 11086-11091
The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma
Authors: Reichert, TE Scheuer, C Day, R Wagner, W Whiteside, TL
Citation: Te. Reichert et al., The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma, CANCER, 91(11), 2001, pp. 2136-2147
Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression
Authors: Reichert, TE Nagashima, S Kashii, Y Stanson, J Gao, G Dou, QP Whiteside, TL
Citation: Te. Reichert et al., Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression, ONCOGENE, 19(4), 2000, pp. 514-525
H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines
Authors: Walter, W Scheuer, C Lingnau, K Reichert, TE Schmitt, E Loos, M Maeurer, MJ
Citation: W. Walter et al., H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines, IMMUNOGENET, 51(10), 2000, pp. 794-804
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanomapatient responding to continued immunization with melanoma-associated peptides
Authors: Jager, E Maeurer, M Hohn, H Karbach, J Jager, D Zidianakis, Z Bakhshandeh-Bath, A Orth, J Neukirch, C Necker, A Reichert, TE Knuth, A
Citation: E. Jager et al., Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanomapatient responding to continued immunization with melanoma-associated peptides, INT J CANC, 86(4), 2000, pp. 538-547
Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice
Authors: Chikamatsu, K Reichert, TE Kashii, Y Saito, T Kawashiri, S Yamamoto, E Whiteside, TL
Citation: K. Chikamatsu et al., Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice, INT J CANC, 82(4), 1999, pp. 532-537
Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes
Authors: Gastman, BR Atarashi, Y Reichert, TE Saito, T Balkir, L Rabinowich, H Whiteside, TL
Citation: Br. Gastman et al., Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes, CANCER RES, 59(20), 1999, pp. 5356-5364
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines
Authors: Reichert, TE Kashii, Y Stanson, J Zeevi, A Whiteside, TL
Citation: Te. Reichert et al., The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines, BR J CANC, 81(5), 1999, pp. 822-831
Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
Authors: Reichert, TE Day, R Wagner, EM Whiteside, TL
Citation: Te. Reichert et al., Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma, CANCER RES, 58(23), 1998, pp. 5344-5347
Risultati: 1-9 |